Sun Pharmaceutical Industries tender offer for InSite Vision ends; to directly acquire shares
As of the expiration of the tender offer on midnight yesterday, 104,216,642 shares of common stock of InSite had been tendered into and not properly withdrawn from the tender offer, Sun Pharma said in a statement.
